Pharma leaders, policy makers discuss COVID-19 impact, way forward for industry
Most are optimistic about the future but accentuate the need for investments in technology and other strategic measures to ensure…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Sudarshan Jain
CDSCO observes lower supply of 15 drugs used for COVID-19 treatment
Asks drug manufacturers associations to ensure adequate production, supply and availability of these 15 drugs
CDSCO anticipates low inventory of cardiac and anti-diabetic medicines, writes to all pharma…
The letter to all the associations from the CDSCO has also requested to take urgent, necessary action to ensure sufficient…
DGFT lifts export ban on paracetamol formulations
Export restrictions on paracetamol APIs to continue, industry hopeful that the government will lift restrictions on APIs as well
‘Prices of key pharma ingredients could rise if coronavirus outbreak in China prolongs’
China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates at $2,405.42 million to India in 2018-19
Indian generic drugmakers may face supply shortages from China if coronavirus drags on
Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China…
Pharma Budget 2020
Pharma experts share their views and insights on the impact and implications of Budget 2020
Budget 2020: Pharma Wishlist
Leaders and experts from the pharma sector share their concerns and expectations from Budget 2020
The Indian Pharmaceutical Industry: Pride and Growth Lever of India
Sudarshan Jain, Secretary General, IPA and Archana Jatkar, Associate Secretary General, IPA reminisce on five significant steps…
Reduce GST, form a separate ministry of pharma, zones for creation of medicines: Indian pharma body…
As per a report prepared by the IPA, at its current rate of seven to eight per cent CAGR, the Indian pharmaceutical industry is…